Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Sarcopenia (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Sarcopenia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Drugs in Development, 2021, provides...
March 2021
102 pages
Smallpox (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Smallpox (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides a...
March 2021
88 pages
Warts (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Warts (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Drugs in Development, 2021, provides an over...
March 2021
117 pages
Migraine - Pipeline Review, H2 2020
US$ 2,000.00
... . The Migraine (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Migraine and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
342 pages
Type 2 Diabetes - Pipeline Review, H2 2020
US$ 2,500.00
... . The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
1251 pages
Non-Hodgkin Lymphoma - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Non-Hodgkin Lymphoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
3999 pages
Schizophrenia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Schizophrenia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Schizophrenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
440 pages
Hepatitis B - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Hepatitis B (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
575 pages
Systemic Lupus Erythematosus - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Systemic Lupus Erythematosus (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Lupus Erythematosus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
816 pages
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020
US$ 2,500.00
... . The Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2020
868 pages
Insomnia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
164 pages
Psoriatic Arthritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Psoriatic Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Psoriatic Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
355 pages
Melanoma - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
3809 pages
Irritable Bowel Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Irritable Bowel Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Irritable Bowel Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
194 pages
Aspergillosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Aspergillosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Aspergillosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
196 pages
Cervical Cancer - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
1768 pages
Obesity - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Obesity (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Obesity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
640 pages
Tuberculosis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Tuberculosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tuberculosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
419 pages
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020
US$ 2,500.00
... . The Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
733 pages
Diphtheria - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diphtheria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Diphtheria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
85 pages
Gouty Arthritis (Gout) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gouty Arthritis (Gout) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
139 pages
